CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 17 filers reported holding CELLECTAR BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $851,000 | -22.3% | 920,000 | 0.0% | 0.03% | -23.1% |
| Q2 2021 | $1,095,000 | -26.1% | 920,000 | 0.0% | 0.04% | -22.0% |
| Q1 2021 | $1,481,000 | -22.6% | 920,000 | 0.0% | 0.05% | -19.4% |
| Q4 2020 | $1,914,000 | +67.7% | 920,000 | 0.0% | 0.06% | +59.0% |
| Q3 2020 | $1,141,000 | -3.1% | 920,000 | 0.0% | 0.04% | -25.0% |
| Q2 2020 | $1,178,000 | -3.9% | 920,000 | 0.0% | 0.05% | -38.1% |
| Q1 2020 | $1,226,000 | -40.8% | 920,000 | 0.0% | 0.08% | -28.2% |
| Q4 2019 | $2,070,000 | +12.5% | 920,000 | 0.0% | 0.12% | -12.0% |
| Q3 2019 | $1,840,000 | -8.3% | 920,000 | 0.0% | 0.13% | -22.7% |
| Q2 2019 | $2,006,000 | – | 920,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 193,510 | $230,276,000 | 0.72% |
| Consonance Capital Management LP | 3,913,000 | $4,656,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 217,500 | $259,000 | 0.13% |
| FNY Investment Advisers, LLC | 220,321 | $262,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 426,561 | $508,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 297,653 | $354,000 | 0.04% |
| Boxer Capital, LLC | 920,000 | $1,095,000 | 0.04% |
| Maven Securities LTD | 650,000 | $793,000 | 0.03% |
| Sterneck Capital Management, LLC | 30,000 | $34,000 | 0.02% |
| 1900 WEALTH MANAGEMENT LLC | 60,000 | $71,000 | 0.01% |